Handbook of Neurotoxicity 2021
DOI: 10.1007/978-3-030-71519-9_75-1
|View full text |Cite
|
Sign up to set email alerts
|

Nature of DSP-4-Induced Neurotoxicity

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2021
2021
2021
2021

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 89 publications
0
1
0
Order By: Relevance
“…Because it crosses the blood-brain barrier, DSP4 can be administered intraperitoneally (IP) [38][39][40] and does not require surgical manipulations. After administration, DSP4 cyclizes to form an aziridinium derivative, which is an irreversible inhibitor of the norepinephrine transporter and inhibits norepinephrine reuptake with long lasting degenerative effects on LC-NA efferents [38][39][40]. Thus, DSP4 eliminates the LC-NA spinal projection, but spares projections of the A5 and A7 NA cell groups [41].…”
Section: Introductionmentioning
confidence: 99%
“…Because it crosses the blood-brain barrier, DSP4 can be administered intraperitoneally (IP) [38][39][40] and does not require surgical manipulations. After administration, DSP4 cyclizes to form an aziridinium derivative, which is an irreversible inhibitor of the norepinephrine transporter and inhibits norepinephrine reuptake with long lasting degenerative effects on LC-NA efferents [38][39][40]. Thus, DSP4 eliminates the LC-NA spinal projection, but spares projections of the A5 and A7 NA cell groups [41].…”
Section: Introductionmentioning
confidence: 99%